Details
Product Details
- Average Rating:
-
2
- Faculty:
-
Kenneth Carter, PhD, ABPP
- Duration:
-
10 Hours 09 Minutes
- Format:
- Audio and Video
- Copyright:
-
Dec 13, 2017
- Product Code:
- POS020716
- Media Type:
-
Digital Seminar
- Access:
- Never expires.
CPD
Continuing Professional Development Certificates
- PESI Australia, in collaboration with PESI in the USA, offers quality online continuing professional development events from the leaders in the field at a standard recognized by professional associations including psychology, social work, occupational therapy, alcohol and drug professionals, counselling and psychotherapy. On completion of the training, a Professional Development Certificate is issued after the individual has answered and submitted a quiz and course evaluation. This online program is worth 10.25 hours CPD.
Additional Info
Program Information
Access for Self-Study (Non-Interactive)
Access never expires for this product.
Objectives
- Analyze the historical antecedents of psychopharmacological products and their relation to today’s psychotropic medications.
- Designate the mechanism of action of today's psychotropic medications and how it relates to your clients.
- Breakdown the process of medication selection and receptor activation/blocking for specific disorders.
- Communicate the side effects including nutritional, cognitive, sexual, and behavioral associated with psychotropic medications.
- Specify how medications are chosen for depressive disorders and specific patient characteristics.
- Compile medication treatment options for your clients with ADHD.
- Determine the unique medication considerations for geriatric clients.
- Analyze future trends, including preventing side effects vs. managing side effects.
- Establish ethical issues specifically relating to the limits of non-prescribers’’ discussion of medications as it relates to clinical psychopharmacology.
- Explore specific ethical issues and their resolve to the everyday practice of clinical psychopharmacology.
Outline
PSYCHOPHARMACOLOGY ETHICS FOR NON-PRESCRIBERS
- Case Study
- Understanding the challenges of psychopharmacology ethics
- Reasons to be knowledgeable about psychopharmacology
- Ways to increase success with medications
- Lessons from other disciplines
- Understanding the limits of non-prescribers’ discussion of medications
- Ethics codes
- Informed consent and medications
- Common questions clients have about medications
- Guidelines for discussing medications with clients
- Collaborating with prescribers
PSYCHOPHARMACOLOGY 101
- The terminology of psychopharmacology
- General overview of the nervous system
- Finding your way around the nervous system
- The parts of the neuron
- How neurons communicate
- What the body does to medications
- What medications do to the body
- Receptors and Ligands
- Routes of administration for medications
- Drug-drug interactions
- Understanding genetic testing
DEPRESSIVE DISORDERS
- Neurobiology of depressive disorders
- Medications for depressive disorders
ANXIETY AND RELATED DISORDERS
- Disorders with anxiety components
- Neurobiology of anxiety disorders
- Medications for anxiety disorders
PSYCHOTIC DISORDERS
- Neurobiology of psychotic disorders
- Medications for psychotic disorders
BIPOLAR DISORDERS
- Neurobiology of bipolar disorders
- Medications for bipolar disorders
ATTENTION DEFICIT HYPERACTIVITY DISORDER
- ADHD diagnostic criteria and basic concepts
- Neurobiology of ADHD
- Medications for ADHD
- Medication delivery systems for ADHD
INSOMNIA
- Sleep and insomnia concepts
- Neurobiology of insomnia
- Medications for insomnia
PHARMACOTHERAPY OF SPECIAL POPULATIONS
- Children
- Geriatric psychopharmacology
- Comorbidity
OVER-THE-COUNTER AND HERBALS
ADDRESSING CLIENTS’ CONCERNS ABOUT MEDICATIONS
RESOURCES TO IMPROVE YOUR KNOWLEDGE
Target Audience
- Psychologists
- Psychiatrists
- Social Workers
- Counselors
- Alcoholism and Drug Abuse Counselors
- Nurses
- Nurse Practitioners
- Psychiatric Nurse Practitioners
- Marriage and Family Therapists
- Case Managers
Reviews
Overall:
5
Total Reviews: 2